Nordic Bioscience

Nordic Bioscience is the leading expert in extracellular matrix (ECM) research. We support some of the largest pharmaceutical companies in preclinical and clinical research with three decades of experience in biomarker development. With more than 650 peer-reviewed publications, our science-driven approach has been the evolving force behind our decades of success. Through our Protein Fingerprint technology, we identify fragments of the ECM that are released from affected tissues and develop blood-based biomarker assays to quantify disease activity with the aim of precision medicine. By quantifying tissue remodeling, our biomarkers provide true prognostic and predictive value, as we can select the...

Biomarkers,predictive biomarkers,translational biomarkers,bioassay,oncology,fibrosis,rheumatoid arthritis,rheumatology,cancer,osteoporosis,osteoarthritis,assay development,alzheimer's,clinical trials,clinical development,serological biomarkers,consultancy,scientific collaboration,neurodegenerative conditions,biotechnology,hepatology,dermatology,cardiovascular diseases,respiratory diseases,gastroenterology,prognostic biomarkers,protein fingerprint,precision medicine,drug development,clinical research,tumor fibrosis,ipf,copd,trial enrichment,and patient stratification

Nordic bioscience operates in the Biotechnology research industry.

Nordic bioscience's revenue is 11m - 100m

Nordic bioscience has 201 - 500 employees.